Bellicum Pharmaceuticals (BLCM) Q2 2023 Earnings

10AugConfirmed
Aug 22
Nov 22
Q4 2022
Q2 2023
-0.93
-0.66
-0.4
-0.13

Details

Expected EPS
N/A
Actual EPS
-0.24
Surprise EPS
-0.24
Surprise Percent
+∞%

Description

Bellicum Pharmaceuticals (BLCM) has reported earnings of -0.24 per share for Q2 2023.

0 Comments

Share your thoughts